radiation therapy for hematologic malignancies - … · radiation therapy for hematologic...
TRANSCRIPT
![Page 1: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/1.jpg)
Radiation Therapy for Hematologic Malignancies
Lymphoma Foundation Canada
Richard Tsang, MD Radiation Oncologist
Princess Margaret Cancer Centre Professor, Dept. Radiation Oncology
University of Toronto
![Page 2: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/2.jpg)
Role of Radiation Therapy
Lymphoma/Hodgkin’s Stage I/II in combination with chemotherapy Some indolent types RT by itself can cure
Multiple Myeloma Bone pain (despite drug treatments) Nerve compression (spinal cord) Local control of plasmacytomas
Leukemia Central nervous system, & total body (transplant)
![Page 3: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/3.jpg)
Radiation Facts
External beam (from Linac or 60Co) Most commonly used for lymphoma
Brachytherapy Sealed radioactive source put into the body For prostate, and gynecologic applications
Radionuclide therapy (radioimmunotherapy) 131Iodine or 90Yttrium tagged with antibody Bexxar or Zevalin Harness the electron effect with short range
![Page 4: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/4.jpg)
Electromagnetic Spectrum
Radiotherapy is the use of ionizing radiation in the treatment of malignancies.
![Page 5: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/5.jpg)
Radiation Therapy: How?
If decision is to have radiation Simulation session – half to 1 hour Scan (CT simulator) Depending on area, may be a mask Possibly tattoo marks
Actual treatment (half hour) Painless, usually multiple sessions (20) Linear accelerator (Linac)
![Page 6: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/6.jpg)
What happens to a patient being considered for Radiation Therapy?
Simulation
Dosimetry/ planning
RT treatment
Consultation
Linac
~ 7
– 10
day
s
![Page 7: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/7.jpg)
Custom Immobilization Mask
![Page 8: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/8.jpg)
CT SimulatorCT Simulator
![Page 9: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/9.jpg)
Linear Accelerator
![Page 10: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/10.jpg)
Radiation Therapist Setting up the Treatment
![Page 11: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/11.jpg)
Radiation therapy technologies Precise targeting Image based 3D planning Intensity modulated beams (IMRT) “Dose painting” Protect normal tissues Quantitative assessments Safe treatment Vigorous quality assurance
Image guidance as required
![Page 12: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/12.jpg)
IMRT: Sinus location
![Page 13: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/13.jpg)
Intensity modulated RT for gastric lymphoma
![Page 14: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/14.jpg)
Radiation Therapy: Lymphoma Hematologic malignancies are very
radiation sensitive Doses used range: 12 Gy for the CNS phase in leukemia 20 Gy for low risk Hodgkin after chemo 30 Gy for most lymphomas 40 Gy for resistant tumors
Much lower than for other cancers Breast cancer (50 Gy), prostate (78 Gy)
![Page 15: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/15.jpg)
Radiation Therapy: Expectations
Daily attendance Monday – Friday Within first day or two, if pain present,
pain may worsen (flare reaction) Within a week or two: tumor if present
will shrink Affect tissues locally only, side effects
are dose and volume dependent
![Page 16: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/16.jpg)
Radiation Therapy: Expectations
Does not interfere with chemotherapy Exception: adriamycin
Does not produce drop in blood counts Exception: very large area of treatment
Fairly well tolerated for most areas For same area, repeatable once
(depending on dose/area treated)
![Page 17: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/17.jpg)
Radiation Therapy: Possible Side Effects
Neck Taste, dryness, swallowing Chest Swallowing, lung reaction/scar Abdomen Nausea, loose stools Pelvis Blood counts Extremities Nil Any site Skin redness (mild), fatigue Late effect* Second malignancy
*Mainly young people with Hodgkin’s
![Page 18: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/18.jpg)
14 months post RT 40 Gy
She did not get radiation pneumonitis
![Page 19: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/19.jpg)
Radiation Therapy: Availability
Around Metro Toronto: Princess Margaret Cancer Centre Sunnybrook Hospital Credit Valley Hospital Lakeridge Health (Oshawa) Southlake Cancer Centre (Newmarket)
There is no significant wait list at Princess
Margaret
![Page 20: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/20.jpg)
Conclusions and Questions
![Page 21: Radiation Therapy for Hematologic Malignancies - … · Radiation Therapy for Hematologic Malignancies . Lymphoma Foundation Canada . Richard Tsang, MD . ... Depending on area, may](https://reader030.vdocuments.us/reader030/viewer/2022021514/5b0dbd4f7f8b9af65e8e17e6/html5/thumbnails/21.jpg)
BNLI: Retrospective cohort study of 2,456 NHL pts SIR of solid cancer in no-RT cohort: 1.0 (95% CI, 0.7-1.4) SIR of solid cancer in RT cohort: 1.2 (95% CI, 0.8-1.7) SEER: Retrospective cohort study of 77,823 NHL pts : SIR of SM in no-RT cohort: 1.13 (95% CI, 1.1-1.2) SIR of SM in RT cohort: 1.18 (95% CI, 1.1-1.2) GISL: Retrospective cohort study of 1,280 DLBCL pts: SIR of SM in no-RT cohort: 1.16 (95% CI, 0.79-1.63) SIR of SM in RT cohort: 0.92 (95% CI, 0.42-1.75)
Large Cohort Studies did not show increased SM risk with addition of RT:
Mudie et al. JCO 24:1568, 2006; Tward et al. Cancer 107:108, 2006; Sacchi et al. Haematologica 93: 298, 2008